Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

736 Articles

Chris Lange | Mar 25, 2015 at 9:15 AM EDT

Major Biotech Is So-So for Short Sellers

The March 13 short interest data in top biotechs have been compared with the end of February figures, and across…

Lee Jackson | Mar 25, 2015 at 8:45 AM EDT

Why Deutsche Bank Says to Buy Gilead and Vertex Pullbacks

Deutsche Bank says that investors have misread the current instances floating around two leading biotech stocks, and they both should…

Jon C. Ogg | Mar 19, 2015 at 8:05 AM EDT

Top Analyst Upgrades and Downgrades: Chesapeake, eBay, Enterprise, Gilead, Newmont, Wynn and More

Thursday's top analyst upgrades and downgrades include Chesapeake Energy, eBay, Enterprise Products Partners, Gilead Sciences, Newmont Mining and Wynn Resorts.

Chris Lange | Mar 18, 2015 at 2:10 PM EDT

How the Weaker Euro Is Impacting Biotech Earnings

Wells Fargo released a report Wednesday that considers the future of major biotech companies in relation to the weak euro.

Chris Lange | Mar 11, 2015 at 9:15 AM EDT

Short Sellers Get More Aggressive on Big Biotech

24/7 Wall St. has reviewed the top biotech companies, and the February 27 short interest data have been compared with…

Jon C. Ogg | Mar 6, 2015 at 12:20 PM EST

After Apple Added to DJIA, at Least 3 More Dow Stocks Could Get Booted

With AT&T dropped from the Dow in favor of Apple, investors may be wondering which Dow stocks could get booted…

Lee Jackson | Feb 27, 2015 at 10:15 AM EST

5 US Companies Focused on Returning Capital to Shareholders

UBS reports that corporations are generating an incredible $1 trillion a year in cash, and the believe these five top…

Chris Lange | Feb 26, 2015 at 9:25 AM EST

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

The short interest data are out for the February 13 settlement date. 24/7 Wall St. has reviewed the top biotech…

Lee Jackson | Feb 24, 2015 at 10:05 AM EST

Top UBS Health Care Stocks to Buy for 2015 and Beyond

Bought as a basket, these four companies could offer long-term investors a perfect compliment of stocks covering the health care…

Lee Jackson | Feb 18, 2015 at 8:25 AM EST

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Here are the four top biotech stocks to buy now according to Deutsche Bank. These leaders have established drugs, solid…

Lee Jackson | Feb 14, 2015 at 9:10 AM EST

Insider Buying Stays Solid as Market Races Toward Record Highs

The stock market continues to act like an aging prize fighter, one that will not give up despite all the…

Chris Lange | Feb 11, 2015 at 9:40 AM EST

Short Sellers Look Scared of Big Biotech

The short interest data are out for the January 30 settlement date. 24/7 Wall St. has reviewed the top biotech…

Chris Lange | Feb 6, 2015 at 12:15 PM EST

Credit Suisse Gives Up on Gilead, Sort Of

Credit Suisse downgraded Gilead Sciences to Neutral and lowered its price target, citing increased competition for hepatitis C drugs.

Jon C. Ogg | Feb 6, 2015 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Best Buy, Gilead, KeyCorp, NBG, Pandora, Staples, Yelp and More

Friday's top analyst upgrades, downgrades and initiations include Best Buy, Gilead Sciences, KeyCorp, National Bank of Greece, Pandora Media, Staples…

Jon C. Ogg | Feb 4, 2015 at 10:45 AM EST

Gilead Dividend and Buyback Different From Amgen’s Strategy

Gilead Sciences has become so large and accumulated enough capital that it has decided to begin paying a dividend, a…

1 … 32 33 34 35 36 … 50

Gilead Sciences : GILD

All Gilead Sciences Articles

Major Biotech Is So-So for Short Sellers

Why Deutsche Bank Says to Buy Gilead and Vertex Pullbacks

Top Analyst Upgrades and Downgrades: Chesapeake, eBay, Enterprise, Gilead, Newmont, Wynn and More

How the Weaker Euro Is Impacting Biotech Earnings

Short Sellers Get More Aggressive on Big Biotech

After Apple Added to DJIA, at Least 3 More Dow Stocks Could Get Booted

5 US Companies Focused on Returning Capital to Shareholders

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

Top UBS Health Care Stocks to Buy for 2015 and Beyond

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Insider Buying Stays Solid as Market Races Toward Record Highs

Short Sellers Look Scared of Big Biotech

Credit Suisse Gives Up on Gilead, Sort Of

Top Analyst Upgrades and Downgrades: Best Buy, Gilead, KeyCorp, NBG, Pandora, Staples, Yelp and More

Gilead Dividend and Buyback Different From Amgen’s Strategy

David Tepper Just Made a $107 Million Bet on Top AI Stock. George Soros Is Holding Puts Against It.

Nuclear Stocks Plunge Tuesday: Oklo Down 5%, Constellation Energy Down 4%, NuScale Down 5%

The Own-Occupation Disability Policy a 41-Year-Old Surgeon Just Renewed at Half Her Old Premium Despite Earning Twice as Much

The Own-Occupation Disability Policy a 41-Year-Old Surgeon Just Renewed at Half Her Old Premium Despite Earning Twice as Much

The USDA Paid Him Rent on 200 Retired Acres. Claiming Social Security Changed the Tax on the Same Check.

David Tepper Just Made a $107 Million Bet on Top AI Stock. George Soros Is Holding Puts Against It.

Nuclear Stocks Plunge Tuesday: Oklo Down 5%, Constellation Energy Down 4%, NuScale Down 5%

Gilead Sciences : GILD

All Gilead Sciences Articles

Major Biotech Is So-So for Short Sellers

Why Deutsche Bank Says to Buy Gilead and Vertex Pullbacks

Top Analyst Upgrades and Downgrades: Chesapeake, eBay, Enterprise, Gilead, Newmont, Wynn and More

How the Weaker Euro Is Impacting Biotech Earnings

Short Sellers Get More Aggressive on Big Biotech

After Apple Added to DJIA, at Least 3 More Dow Stocks Could Get Booted

5 US Companies Focused on Returning Capital to Shareholders

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

Top UBS Health Care Stocks to Buy for 2015 and Beyond

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Insider Buying Stays Solid as Market Races Toward Record Highs

Short Sellers Look Scared of Big Biotech

Credit Suisse Gives Up on Gilead, Sort Of

Top Analyst Upgrades and Downgrades: Best Buy, Gilead, KeyCorp, NBG, Pandora, Staples, Yelp and More

Gilead Dividend and Buyback Different From Amgen’s Strategy

David Tepper Just Made a $107 Million Bet on Top AI Stock. George Soros Is Holding Puts Against It.

Nuclear Stocks Plunge Tuesday: Oklo Down 5%, Constellation Energy Down 4%, NuScale Down 5%

The Own-Occupation Disability Policy a 41-Year-Old Surgeon Just Renewed at Half Her Old Premium Despite Earning Twice as Much

Featured Reads

The Own-Occupation Disability Policy a 41-Year-Old Surgeon Just Renewed at Half Her Old Premium Despite Earning Twice as Much

The USDA Paid Him Rent on 200 Retired Acres. Claiming Social Security Changed the Tax on the Same Check.